443 results on '"Ball, Jonathan K."'
Search Results
2. Recombinant H77C gpE1/gpE2 heterodimer elicits superior HCV cross-neutralisation than H77C gpE2 alone
3. Arbovirus circulation, epidemiology and spatiotemporal distribution in Uganda
4. Evaluation of the relative potential for contact and doffing transmission of SARS-CoV-2 by a range of personal protective equipment materials
5. An Antigenically Diverse, Representative Panel of Envelope Glycoproteins for Hepatitis C Virus Vaccine Development
6. Coronavirus (CoV) proteins in GtoPdb v.2023.3
7. Cross-genotype AR3-specific neutralizing antibodies confer long-term protection in injecting drug users after HCV clearance
8. Discovery of Novel Coronaviruses in Rodents
9. Adjuvant formulated virus-like particles expressing native-like forms of the Lassa virus envelope surface glycoprotein are immunogenic and induce antibodies with broadly neutralizing activity
10. Polyvalent immunization elicits a synergistic broadly neutralizing immune response to hypervariable region 1 variants of hepatitis C virus
11. Role of HVR1 sequence similarity in the cross-genotypic neutralization of HCV
12. Cloning and Analysis of Authentic Patient-Derived HCV E1/E2 Glycoproteins
13. InFusion Cloning for the Generation of Biologically Relevant HCV Chimeric Molecular Clones
14. Standardized Method for the Study of Antibody Neutralization of HCV Pseudoparticles (HCVpp)
15. Molecular and biological characterisation of the human immunodeficiency virus type 1
16. Non-ionic detergents facilitate non-specific binding of M13 bacteriophage to polystyrene surfaces
17. Scavenger receptor class B type I genetic variants associated with disease severity in chronic hepatitis C virus infection
18. Optimization of the pseudoparticle system for standardized assessments of neutralizing antibodies against hepatitis C virus
19. The Impact of Real-Time Whole-Genome Sequencing in Controlling Healthcare-Associated SARS-CoV-2 Outbreaks
20. Coronavirus (CoV) proteins in GtoPdb v.2022.3
21. A Qualitative Evaluation of the Barriers and Enablers for Implementation of an Asymptomatic SARS-CoV-2 Testing Service at the University of Nottingham: A Multi-Site Higher Education Setting in England
22. Hepatitis C subtyping assay failure in UK patients born in sub‐Saharan Africa: Implications for global treatment and elimination
23. Workforce Experiences of a Rapidly Established SARS-CoV-2 Asymptomatic Testing Service in a Higher Education Setting: A Qualitative Study
24. The past, present and future of neutralizing antibodies for hepatitis C virus
25. Trichodysplasia Spinulosa Polyomavirus in Respiratory Tract of Immunocompromised Child
26. Human parainfluenza 2 & 4: Clinical and genetic epidemiology in the UK, 2013–2017, reveals distinct disease features and co‐circulating genomic subtypes
27. In vitro evolution predicts emerging SARS-CoV-2 mutations with high affinity for ACE2 and cross-species binding
28. Exploring the Psychological Impacts of COVID-19 Social Restrictions on International University Students: A Qualitative Study
29. Enterovirus D68 epidemic, UK, 2018, was caused by subclades B3 and D1, predominantly in children and adults, respectively, with both subclades exhibiting extensive genetic diversity
30. Simultaneous determination of HCV genotype and NS5B resistance associated substitutions using dried serum spots from São Paulo state, Brazil
31. Optimization of the pseudoparticle system for standardized assessments of neutralizing antibodies against hepatitis C virus
32. The HCV Envelope Glycoprotein Down-Modulates NF-κB Signalling and Associates With Stimulation of the Host Endoplasmic Reticulum Stress Pathway
33. Discovery of Novel Coronaviruses in Rodents
34. The Impact of Real-Time Whole-Genome Sequencing in Controlling Healthcare-Associated SARS-CoV-2 Outbreaks
35. Human Combinatorial Libraries Yield Rare Antibodies That Broadly Neutralize Hepatitis C Virus
36. Human Parainfluenza 2 & 4: clinical and genetic epidemiology in the UK, 2013-2017, reveals distinct disease features and co-circulating genomic subtypes
37. Relationship Between Anxiety, Depression, and Susceptibility to Severe Acute Respiratory Syndrome Coronavirus 2 Infection: Proof of Concept
38. In vitro evolution predicts emerging CoV-2 mutations with high affinity for ACE2 and cross-species binding
39. Hepatitis C subtyping assay failure in UK patients born in Sub-Saharan Africa: implications for global treatment and elimination
40. Enterovirus D68 epidemic, UK, 2018, was caused by subclades B3 and D1, predominantly in children and adults respectively, with both subclades exhibiting extensive genetic diversity
41. An antigenically diverse, representative panel of envelope glycoproteins for HCV vaccine development
42. Two doses of the SARS-CoV-2 BNT162b2 vaccine enhance antibody responses to variants in individuals with prior SARS-CoV-2 infection
43. Scavenger receptor class B type I genetic variants associated with disease severity in chronic hepatitis C virus infection.
44. Hepatitis C subtyping assay failure in UK patients born in sub‐Saharan Africa: Implications for global treatment and elimination.
45. Challenges on the development of a pseudotyping assay for Zika glycoproteins
46. Coronavirus (CoV) proteins in GtoPdb v.2021.3
47. Immunogenicity of a new gorilla adenovirus vaccine candidate for COVID-19
48. TT Virus Infection in Patients with Hepatitis C: Frequency, Persistence, and Sequence Heterogeneity
49. Real-world outcomes of DAA treatment and retreatment in UK-based patients infected with HCV genotypes/subtypes endemic in Africa
50. Real-World Outcomes of Direct-Acting Antiviral Treatment and Retreatment in United Kingdom-Based Patients Infected With Hepatitis C Virus Genotypes/Subtypes Endemic in Africa
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.